The Epileptic Encephalopathy Gene Panel by NGS / EDTA Blood is a comprehensive genetic test that analyzes multiple genes associated with severe childhood-onset epileptic disorders. It helps identify underlying genetic causes, supports early diagnosis, and guides targeted treatment decisions. Performed using advanced next-generation sequencing at Metropolis Healthcare, this test offers high accuracy and valuable clinical insights. It is especially useful for patients with unexplained seizures, developmental delays, or treatment-resistant epilepsy.
Price:
Rs. 21,000.00
Sample Type: EDTA BLOOD
Fasting Not Requierd
Frequently Asked Questions (FAQ's):
What does the Epileptic Encephalopathy Gene Panel by NGS include?
This panel at Metropolis Healthcare analyzes multiple genes linked to epileptic encephalopathies using next-generation sequencing.
How does Metropolis Healthcare perform this genetic test?
Metropolis Healthcare uses advanced NGS technology to detect disease-causing variants with high accuracy from an EDTA blood sample.
Who should take this test?
Patients with unexplained seizures, early-onset epilepsy, developmental delay, or suspected genetic epilepsy may benefit from this test at Metropolis Healthcare.
Why is genetic testing important for epileptic encephalopathy?
Metropolis Healthcare provides this test to help identify the root genetic cause, support precise diagnosis, and guide personalized treatment.
What sample is required for this test?
Metropolis Healthcare processes a standard EDTA blood sample to perform the full NGS-based gene analysis.
How long does it take to receive results?
Metropolis Healthcare typically reports results within a clinically relevant turnaround time based on the complexity of the analysis.
Can this test help with treatment planning?
Yes, doctors often use Metropolis Healthcare’s genetic findings to choose targeted therapies and manage epilepsy more effectively.
Is this test helpful for families with a history of epilepsy?
Yes, Metropolis Healthcare recommends genetic evaluation for families with recurrent or inherited patterns of epilepsy to understand risk and recurrence.